BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 28649088)

  • 1. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury.
    Zhou B; Zeng S; Li N; Yu L; Yang G; Yang Y; Zhang X; Fang M; Xia J; Xu Y
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):675-684. PubMed ID: 28153879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells.
    Yu Y; Li Y; Peng H; Song Q; Da X; Li H; He Z; Ren X; Xu C; Yao Y; Wang QK
    J Biol Chem; 2022 Apr; 298(4):101759. PubMed ID: 35202649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
    Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
    Huang C; Zhao J; Zhu Y
    J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.
    Shi N; Li CX; Cui XB; Tomarev SI; Chen SY
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):446-454. PubMed ID: 28062493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.
    Zhou LJ; Chen XY; Liu SP; Zhang LL; Xu YN; Mu PW; Geng DF; Tan Z
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
    van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
    Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
    Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ
    Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice.
    Tzeng BH; Chen YH; Huang CH; Lin SS; Lee KR; Chen CC
    Cardiovasc Res; 2012 Dec; 96(3):533-42. PubMed ID: 22886848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
    Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
    Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.